和仁科技(300550.SZ):擬與通策口腔共同設立和仁通策口腔數字化信息管理
格隆匯1月15日丨和仁科技(300550.SZ)公佈,公司(“甲方”)擬與浙江通策口腔醫院投資管理集團有限公司(簡稱“通策口腔”、“乙方”)共同設立和仁通策口腔數字化信息管理有限公司(暫定名,最終以市場監督管理部門核定為準,以下簡稱“目標公司”、“合資公司”)。目標公司註冊資本擬為人民幣2000萬元,其中,甲方擬認繳註冊資本人民幣1020萬元,持股比例為51%;乙方擬認繳註冊資本人民幣980萬元,持股比例為49%。本次交易完成後,公司持有目標公司51%的股權,目標公司成為和仁科技的控股子公司,納入公司合併報表範圍。
本次對外投資新設合資公司暨關聯交易事項系充分利用各方的優勢資源,整合口腔醫療服務的2b、2c端,建立大的口腔數字化生態系統,構建口腔數字化信息管理及服務雲平台。基於SAAS軟件提供數字化醫院的運營管理、決策支持等解決方案,通過打造數字底座、數智大腦,支撐口腔醫療機構運營平台化轉型,以患者為中心、以患者為基本點,打通所有的信息傳輸環節,實現醫院系統的整合與問題解決;賦能醫生、客服、及管理人員,以數字化驅動流程再造,讓設備、機器、後台能夠解決的問題自動化解決,減少醫生及客服人員的重複性勞動;同時,以先進和穩定的雲化信息系統為依託,以數據的綜合治理和融合利用為抓手,基於乙方實際業務需求,打造“智慧醫療”“智慧服務”“智慧管理”“智慧運營”以及“智慧供應鏈”體系,完善業務流程和業務閉環,提高服務及管理的效率和質量。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.